AI Test Unlocks Precision Prostate Cancer Treatment, Saving Lives and Costs
A new AI test can identify which men with high-risk prostate cancer will benefit most from the life-extending drug abiraterone, potentially saving lives and NHS costs by avoiding unnecessary treatment for those unlikely to benefit.